Collectively, our results show that the intradermal infection of Atg5-deficient mice with the LVS at the doses of 5 × 105 CFU/mouse, 5 × 106 CFU/mouse and 5 × 107 CFU/mouse resulted in 70%, 50% and 30% survival, respectively. The gene discussed is ATG5; the disease is infection.